Phase I and Pharmacokinetic Study of Inotuzumab Ozogamicin (CMC- 544) as a Single Agent in Japanese Patients with Follicular Lymphoma Pretreated with Rituximab.

Autor: Tobinai, Kensei, Ogura, Michinori, Hatake, Kiyohiko, Kobayashi, Yukio *, Watanabe, Takashi *, Uchida, Toshiki *, Kasai, Masanobu *, Yokoyama, Masahiro *, Terui, Yasuhito, Ono, Chiho *, Akiyama, Masanao *, Ohata, Junko *
Zdroj: In Blood 16 November 2008 112(11):1565-1565
Databáze: ScienceDirect